| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |